Timothy Edwin Kelly - Jul 29, 2024 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role: Chief Financial Officer
Signature: /s/ Alex Nemiroff, as Attorney-in-Fact
Stock symbol: PRAX
Transactions as of: Jul 29, 2024
Transactions value $: $0
Form type: 4
Date filed: 7/31/2024, 09:00 PM
Previous filing: May 20, 2024
Next filing: Nov 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRAX	Common Stock	Award	$0	+7.8K	+179.72%	$0.00	12.1K	Jul 29, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRAX	Stock Option (Right to Buy)	Award	$0	+36.4K		$0.00	36.4K	Jul 29, 2024	Common Stock	36.4K	$56.94	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Kelly was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date.
F2	The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.

Content

Mr. Kelly was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date.

The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.